Ledger.Open graph →
SEC Form D · filed June 30, 2016

Nortis Inc

Offering
$5.0M
Sold
—
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SEATTLE, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Sharon K. Everson · Seattle, WADirectorThomas L. Neumann · Seattle, WAExec · DirectorMary E. Harrison · Seattle, WADirectorAlan C. Nelson · Seattle, WAExec · DirectorWalter L. Robb · Seattle, WADirectorDeborah A. Golden · Effingham, ILDirectorKaname N. Yamanaka · LOWELL, MADirectorJames R. Stewart · Effingham, ILExec · DirectorWehnua N. Zhang · Lowell, MAExec · DirectorJoseph A. Cohen · New York, NYDirectorEric Kish · Boston, MADirectorHealthcare Portfolio Ii, L.L.C · Oak Brook, ILExec · DirectorInland Private Capital Corporation · Oak Brook, ILExec · DirectorHealthcare Portfolio II Exchange, L.L.C · Oak Brook, ILDirectorBrent N. Carey · Long Beach, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗